Publications by authors named "Julia Morell"
Article Synopsis
- There is limited real-world data on COVID-19 management in patients with hematologic diseases (HD) during the Omicron variant phase, prompting this study to evaluate clinical outcomes and risk factors.
- A review of 692 HD patients from December 2021 to May 2023 revealed that a significant portion went untreated, with a low COVID-19 mortality rate, while specific antiviral treatments were linked to varying outcomes based on disease severity.
- Key findings indicate that older age, certain treatment procedures, and incomplete vaccinations heightened the risk of severe COVID-19 outcomes, emphasizing the need for complete vaccinations to improve management in this vulnerable population.
Article Synopsis
- This study examined the effects of two antiviral treatments, remdesivir and nirmatrelvir/ritonavir, on hematological patients infected with SARS-CoV-2 during the Omicron period, using data from a Spanish registry collected from December 2021 to April 2023.
- Out of 466 patients analyzed, those treated with nirmatrelvir/ritonavir had a low COVID-19-related mortality rate of 1.3%, primarily used in mild cases, while remdesivir, used for moderate to severe cases, showed a higher mortality rate of 9%.
- The study found that male gender was linked to lower mortality risk while corticosteroid use and co-infections increased risk, and highlighted that
Use of high-power diode laser at 1060 nm for the treatment of vascular lesions.
Gabriel Buendía Bordera Jorge Gaviria Parada Maribel Martí Giménez María de Los Llanos Pérez Júlia Oliva Morell
J Vasc Surg Cases Innov Tech
December 2019
The use of 1060-nm wavelength light emitted from a high-power diode laser is a novel method for the removal of vascular lesions. Two Caucasian women with Fitzpatrick skin phototype II, who had various vascular lesions, were treated with a 1060-nm high-power diode laser, applying a fluence of 120 J/cm and a single pulse duration of 74 milliseconds. Immediate results were that the cherry angiomas became dark and a scab was formed (that remitted 2 weeks after treatment); the telangiectasias and venulectasias disappeared immediately.
View Article and Find Full Text PDF